How Much Did Agelessrx Raise?
Funding & Key Investors

AgelessRx has successfully secured a significant capital injection, marking a pivotal moment in its corporate trajectory. With a total funding accumulation of $5.5M, the firm is well-positioned to scale its operations within the competitive longevity sector. This latest financing round, which contributed $5.5M to the company's balance sheet, underscores investor confidence in the firm's ability to bridge the gap between advanced medical research and consumer-facing health solutions.

What is Agelessrx?

Agelessrx
Hospitals & Physicians ClinicsMedical Practice Management

AgelessRx operates at the intersection of biotechnology and preventative wellness, providing a digital platform for science-backed longevity treatments. By focusing on healthspan optimization, the company offers a curated suite of interventions, including Metformin and NAD+ precursors, designed to address metabolic, cardiovascular, and cognitive health. The platform distinguishes itself through a rigorous adherence to expert medical protocols, ensuring that longevity science is not only accessible but also clinically validated for a broad demographic. By streamlining the delivery of specialized wellness products, AgelessRx effectively democratizes access to treatments that were previously confined to niche clinical settings, thereby establishing a robust market presence in the burgeoning longevity economy.

How much funding has Agelessrx raised?

Agelessrx has raised a total of $5.5M across 1 funding round:

2026

Private Equity

$5.5M

Private Equity (2026): $5.5M, investors not publicly disclosed

Key Investors in Agelessrx

Undisclosed Investor

An institutional capital provider specializing in late-stage growth equity and strategic enterprise-level investments.

What's next for Agelessrx?

With this major strategic investment, AgelessRx is poised to accelerate its research and development initiatives, potentially expanding its product portfolio to include more sophisticated diagnostic and therapeutic tools. The company is expected to leverage this capital to enhance its digital infrastructure, ensuring seamless integration between patient health data and personalized treatment plans. As the firm transitions into a more mature phase of its lifecycle, the focus will likely shift toward scaling its distribution networks and deepening its clinical partnerships. This strategic expansion will be critical in maintaining its competitive edge as the global demand for longevity-focused health interventions continues to rise, positioning AgelessRx as a leader in the proactive management of human healthspan.

See full Agelessrx company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Hospitals & Physicians ClinicsPhysicians Clinics
Dental Practice ManagementHospitals & Physicians Clinics
Hospitals & Physicians ClinicsMedical & Surgical HospitalsHealthcare ServicesMental Health & Rehabilitation Facilities
Dental Practice ManagementHospitals & Physicians Clinics

Frequently Asked Questions Regarding Agelessrx Financial Insights

What are the most recent funding rounds that Agelessrx has completed, and what were the funding rounds?
Agelessrx has recently completed 1 funding rounds: Private Equity on Mar 17, 2026.
What is the total amount of funding Agelessrx has raised to date?
Agelessrx has raised a total of $5.5M in funding to date.
How many funding rounds has Agelessrx completed?
Agelessrx has completed 1 funding rounds.
How much funding did Agelessrx raise in its most recent funding round?
Agelessrx raised $5.5M in its most recent funding round.
Which was the largest funding round in Agelessrx's history?
The largest funding round in Agelessrx's history was $5.5M.
See more information about Agelessrx